GlobalData on MSN
Apertura and NIH institutes to test gene therapy for NPC1
The Ara Parseghian Medical Research Fund will provide financial backing for the multi-year research effort.
Nairobi, Kenya - July 9, 2026 - The United Nations Development Programme (UNDP) and TAILG, a leading electric mobility ...
CDT. Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics. ITASCA ...
Interesting Engineering on MSN
NVIDIA expands open-source LeRobot with humanoid AI tools for faster robot development
NVIDIA and Hugging Face have expanded their collaboration to bring new AI models and ...
VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has begun cell line development ...
This signing marks a significant milestone in TAILG’s global green strategy and represents another important initiative by ...
Celltrion Testing Access Program Expands Availability of Therapeutic Drug Monitoring to Support Patient Transition to ...
Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today ...
American Fusion Inc. (OTC: AMFN) (“American Fusion” or the “Company”), a company developing advanced fusion energy technologies, including its Texatron™ Fusion Engine™ platform, today announced ...
As concerns over drinking water contaminants such as PFAS, lead, microplastics, volatile organic compounds (VOCs), and other ...
More affordable housing is being proposed in Portland, this time off Forest Avenue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results